Registry for spontaneous coronary artery dissection in Switzerland
Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)
University Hospital, Geneva · NCT04457544
This study is creating a registry to collect information about spontaneous coronary artery dissection in Switzerland to help improve diagnosis and treatment for young women affected by this condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Geneva (other) |
| Locations | 1 site (Geneva) |
| Trial ID | NCT04457544 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a national registry for spontaneous coronary artery dissection (SCAD) in Switzerland. It focuses on understanding the natural history, outcomes, and treatments of SCAD, which primarily affects young women without traditional cardiovascular risk factors. By collecting data from patients diagnosed with SCAD, the registry seeks to improve timely diagnosis and clinical follow-up, addressing the gaps in knowledge surrounding this underdiagnosed condition. The study will include patients who are newly diagnosed or diagnosed within the last five years.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18 and older who have been newly diagnosed with SCAD or diagnosed within the last five years.
Not a fit: Patients with atherosclerotic or iatrogenic coronary dissection will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnosis and management of SCAD, ultimately reducing adverse cardiac outcomes.
How similar studies have performed: While SCAD is a relatively underexplored area, the establishment of registries has shown promise in other conditions, suggesting potential for success in this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject is ≥18 years of age. * Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years. * Subject must be willing to sign a Patient Informed Consent (PIC). Exclusion Criteria: * Patient unwilling or unable to provide informed consent. * Patients with atherosclerotic or iatrogenic coronary dissection.
Where this trial is running
Geneva
- Geneva University Hospitals — Geneva, Switzerland (RECRUITING)
Study contacts
- Principal investigator: Sophie Degrauwe, Dr — Hopitaux universitaires de Geneve
- Study coordinator: Sophie Degrauwe, Dr
- Email: sophie.degrauwe@hcuge.ch
- Phone: +41795530294
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Spontaneous Coronary Artery Dissection